{"id":35968,"date":"2024-06-20T11:10:13","date_gmt":"2024-06-20T09:10:13","guid":{"rendered":"https:\/\/www.abcsg.org\/abcsg-veroeffentlichung-im-renommierten-journal-molecular-oncology-zum-thema-ctdna-sequenzierung-bei-brustkrebs\/"},"modified":"2024-06-20T11:12:55","modified_gmt":"2024-06-20T09:12:55","slug":"abcsg-veroeffentlichung-im-renommierten-journal-molecular-oncology-zum-thema-ctdna-sequenzierung-bei-brustkrebs","status":"publish","type":"post","link":"https:\/\/www.abcsg.org\/en\/abcsg-veroeffentlichung-im-renommierten-journal-molecular-oncology-zum-thema-ctdna-sequenzierung-bei-brustkrebs\/","title":{"rendered":"Prestigious Journal &#8216;Molecular Oncology&#8217; Publishes on ctDNA Sequencing in Breast Cancer"},"content":{"rendered":"<p>We are thrilled to announce the publication of our latest research in the prestigious journal Molecular Oncology! The study entitled &#8220;Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression&#8221; represents a significant advancement in breast cancer research.<br \/>\n<!--more--><\/p>\n<p><strong>Key Highlights<\/strong><\/p>\n<p>Liquid biopsy, particularly ctDNA analysis, is revolutionizing cancer care by enabling early detection, monitoring metastasis, and guiding mutation-targeted therapies. It provides real-time insights into tumor dynamics, facilitating personalized treatment and improving patients&#8217; quality of life. Routine applications such as PIK3CA and ESR1 mutation testing demonstrate the transformative impact of this non-invasive approach.<\/p>\n<p><a href=\"https:\/\/doi.org\/10.1002\/1878-0261.13671\">https:\/\/doi.org\/10.1002\/1878-0261.13671<\/a><\/p>\n<p><a href=\"https:\/\/www.abcsg.org\/wp\/wp-content\/uploads\/2024\/06\/Molecular-Oncology-2024-Klocker-Clinical-applications-of-next\u2010generation-sequencing\u2010based-ctDNA-analyses-in-breast.pdf\" target=\"_blank\" target=\"_blank\" rel=\"noopener\">Download PDF<\/a><\/p>\n<p>ABCSG President Prof. Michael Gnant highlights Austria&#8217;s leadership in this field: &#8220;<em>Austria continues to be at the forefront of breast cancer research, and this publication underscores our commitment to advancing science and improving patient outcomes.<\/em>&#8220;<\/p>\n<p>Prof. Gabriel Rinnerthaler, mentor of young researcher Dr. Eva Valentina Klocker, first author of the paper from the Medical University of Graz, highlights the opportunities for young researchers within the ABCSG: &#8220;<em>As a young researcher, the ABCSG provides an incredible platform to contribute to groundbreaking work and publish impactful papers.<\/em>\u201d<\/p>\n<p>Prof. Marija Balic, former Head of the Research Unit FE Translational Breast Cancer Research at the Medical University of Graz and now Co-Director of the Magee Womens Cancer Program at the University of Pittsburgh School of Medicine and Director of Translational Research at NSABP, reflects on the collaborative spirit: &#8220;<em>This publication is a testament to the strong international collaborations and relentless pursuit of excellence in translational research.<\/em>&#8220;<\/p>\n<p>We are extremely proud of the dedication and hard work of our team as they continue to push the boundaries of cancer research and treatment.<\/p>\n<p>Mol Oncol, 2024 Jun 12. doi: 10.1002\/1878-0261.13671. Online ahead of print.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are thrilled to announce the publication of our latest research in the prestigious journal Molecular Oncology! The study entitled &#8220;Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression&#8221; represents a significant advancement in breast cancer research.<\/p>\n","protected":false},"author":1,"featured_media":35965,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[505],"tags":[584],"class_list":["post-35968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-50-publikationen-en"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-02 10:04:26","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/posts\/35968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/comments?post=35968"}],"version-history":[{"count":2,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/posts\/35968\/revisions"}],"predecessor-version":[{"id":35970,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/posts\/35968\/revisions\/35970"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/media\/35965"}],"wp:attachment":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/media?parent=35968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/categories?post=35968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags?post=35968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}